Single Anastomosis Duodenal Switch: 1-Year Outcomes

被引:18
作者
Cottam, Daniel [1 ]
Roslin, Mitchell [2 ]
Enochs, Paul [3 ]
Metz, Matthew [4 ]
Portenier, Dana [5 ]
Smith, Dennis [6 ]
机构
[1] Bariatr Med Inst, 1046 E 100 S, Salt Lake City, UT 84102 USA
[2] Lenox Hill Hosp, New York, NY 10021 USA
[3] Bariatr Specialists North Carolina, Cary, NC USA
[4] Rose Med Ctr, Denver, CO USA
[5] Duke Clin, Durham, NC USA
[6] WellStar Med Grp Comprehens Bariatr Serv, Marietta, GA USA
关键词
SADS; Type 2 diabetes mellitus; GERD; Y GASTRIC BYPASS; PARATHYROID-HORMONE; SECONDARY HYPERPARATHYROIDISM; BILIOPANCREATIC DIVERSION; SLEEVE GASTRECTOMY; POSITION STATEMENT; BARIATRIC SURGERY; MORBID-OBESITY; CALCIUM; PTH;
D O I
10.1007/s11695-019-04352-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction Single-anastomosis duodenal switch has been suggested to be an effective bariatric procedure that offers excellent weight loss and by lengthening the common channel the potential to reduce micronutrient deficiencies. Purpose To evaluate the weight loss, comorbidity resolution and the 1-year nutritional outcomes of the single-anastomosis duodenal switch (SADS) procedure. Setting Multiple US Hospitals. Methods From October 2014 to January 2017, 120 patients were enrolled at six sites across the USA and underwent the SADS procedure. Weight loss, comorbidities, quality of life, and adverse events were followed post-procedure for 12 months. Results At 1, 6, and 12 months, 98.3%, 85.5%, and 77.1% of the patients were available for assessment, respectively. At 12 months, patients showed significantly reduced body mass index when compared to baseline (46.8 +/- 5.8 vs 29.8 +/- 4.4, P < 0.001 respectively). Sixty-five patients had type 2 diabetes at baseline; however, 11 patients lost to follow-up. Of the available data (54 patients), 96.3% of the patients had a resolution of type 2 diabetes by 12 months with a mean A1C reduction from 7.8 +/- 1.6 to 5.3 +/- 0.7. Additionally, there were reductions in hyperlipidemia, sleep apnea, and hypertension at 12 months. Patient gastroesophageal reflux disease satisfaction and quality of life (SF-36) scores were significantly higher at 12 months post-procedure (P < 0.001 in all cases) while 12-month protein levels remained at normal values. There were abnormalities of parathyroid hormone and vitamin D at 1 year with all other nutritional markers being not significantly different at 1 year from baseline. There were 10, IIIb, or greater complications according to the Clavien-Dindo scoring system during the study period, not all of which were related to the surgery. Conclusions SADS is a highly efficacious weight loss procedure with significant comorbidity reduction at 1 year. At 1 year, complications and vitamin and mineral deficits appear to be consistent with other malabsorption operations. Long-term follow-up is needed, especially around complications and vitamin deficiencies.
引用
收藏
页码:1506 / 1514
页数:9
相关论文
共 27 条
  • [1] American Society for Metabolic and Bariatric Surgery updated position statement on sleeve gastrectomy as a bariatric procedure
    Ali, Mohamed
    El Chaar, Maher
    Ghiassi, Saber
    Rogers, Ann M.
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2017, 13 (10) : 1652 - 1657
  • [2] Fracture Risk After Gastric Bypass Surgery: A Retrospective Cohort Study
    Axelsson, Kristian F.
    Werling, Malin
    Eliasson, Bjorn
    Szabo, Eva
    Naslund, Ingmar
    Wedel, Hans
    Lundh, Dan
    Lorentzon, Mattias
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (12) : 2122 - 2131
  • [3] An Analysis of Mid-Term Complications, Weight Loss, and Type 2 Diabetes Resolution of Stomach Intestinal Pylorus-Sparing Surgery (SIPS) Versus Roux-En-Y Gastric Bypass (RYGB) with Three-Year Follow-Up
    Cottam, Austin
    Cottam, Daniel
    Zaveri, Hinali
    Cottam, Samuel
    Surve, Amit
    Medlin, Walter
    Richards, Christina
    [J]. OBESITY SURGERY, 2018, 28 (09) : 2894 - 2902
  • [4] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [5] ASMBS Position Statement on Postprandial Hyperinsulinemic H ypoglycemia after Bariatric Surgery
    Eisenberg, Dan
    Azagury, Dan E.
    Ghiassi, Saber
    Grover, Brandon T.
    Kim, Julie J.
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2017, 13 (03) : 371 - 378
  • [6] Enochs P, SURG OBES RELAT DIS
  • [7] Gastroesophageal reflux disease and Barrett's esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication
    Genco, Alfredo
    Soricelli, Emanuele
    Casella, Giovanni
    Maselli, Roberta
    Castagneto-Gissey, Lidia
    Di Lorenzo, Nicola
    Basso, Nicola
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2017, 13 (04) : 568 - 574
  • [8] The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery
    Hamoui, N
    Kim, K
    Anthone, G
    Crookes, PF
    [J]. ARCHIVES OF SURGERY, 2003, 138 (08) : 891 - 896
  • [9] The biliopancreatic diversion with the duodenal switch: Results beyond 10 years
    Hess, DS
    Hess, DW
    Oakley, RS
    [J]. OBESITY SURGERY, 2005, 15 (03) : 408 - 416
  • [10] Secondary Hyperparathyroidism, Vitamin D Sufficiency, and Serum Calcium 5 Years After Gastric Bypass and Duodenal Switch
    Hewitt, Stephen
    Sovik, Torgeir T.
    Aasheim, Erlend T.
    Kristinsson, Jon
    Jahnsen, Jorgen
    Birketvedt, Grethe S.
    Bohmer, Thomas
    Eriksen, Erik F.
    Mala, Tom
    [J]. OBESITY SURGERY, 2013, 23 (03) : 384 - 390